K-ras cancer genemutations in lung tumors from female Swiss (CD-1)mice exposed transplacentally to 3′-azido-3′-deoxythymidine

Environmental and Molecular Mutagenesis

Volumn 49, Issue 9, 2008, Pages 720-726

  Koujitani, Takatoshi ^a   Ton, Tai Vu T ^a   Lahousse, Stephanie A ^a   Hong, Hue Hua L ^a   Wakamatsu, Nobuko ^a,b   Sills, Robert C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

K ras oncogene; Mouse gestation; Nucleoside reverse transcriptase inhibitor (NRTI); Transplacental carcinogenesis; Zidovudine

Indexed keywords

8 HYDROXYGUANINE; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; LUNG TUMOR; MOUSE; NONHUMAN; ONCOGENE K RAS; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; SWISS WEBSTER MOUSE;

ANIMALS; FEMALE; GENES, RAS; LUNG NEOPLASMS; MALE; MATERNAL EXPOSURE; MICE; MUTATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX FACTORS; ZIDOVUDINE;

MUS;

EID: 58049192768     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20420     Document Type: Article

References (48)

1. Ayers KM, Torrey CE, Reynold DJ. 1997. A transplacental carcinogenicity bioassay in CD-1 mice with zidovudine. Fundam Appl Toxicol 38:195-198.
2. Bhana N, Ormrod D, Perry CM, Figgitt DP. 2002. Zidovudine: A review of its use in the management of vertically-acquired pediatric HIV infection. Paediatr Drugs 4:515-553.
3. Bialkowska A, Bialkowski K, Gerschenson M, Diwan BA, Jones AB, Olivero OA, Poirier MC, Anderson LM, Kasprzak KS, Sipowicz MA. 2000. Oxidative DNA damage in fetal tissues after transplacental exposure to 3′-azido- 3′-deoxythymidine (AZT). Carcinogenesis 21:1059-1062.
4. Chan SS, Santos JH, Meyer JN, Mandavilli BS, Cook DJ Jr, McCash CL, Kissling GE, Nyska A, Foley JF, vanHouton B, Copeland WC, Walker VE, Witt KL, Bishop JB. 2007. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination. Environ Mol Mutagen 48:190-200.
5. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, Alnwick DJ, Rogers M, Shaffer N. 2000. Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. JAMA 283:1175-1182.
6. Dertinger SD, Torous DK, Tometsko KR. 1996. Induction of micronuclei by low doses of azidothymidine (AZT). Mutat Res 368:301-307.
7. Devereux TR, Anderson MW, Belinsky SA. 1991. Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Carcinogenesis 12:299-303.
8. Devereux TR, Belinsky SA, Maronpot RR, White CM, Hegi ME, Patel AC, Foley JF, Greenwell A, Anderson MW. 1993. Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains. Mol Carcinog 8:177-185.
9. Diwan BA, Riggs CW, Logsdon D, Hairres DC, Olivero OA, Rice JM, Yuspa SH, Poirier MC, Anderson LM. 1999. Multiorgan transplacental and neonatal carcinogenicity of 3′-azido-3′-deoxythymidine in mice. Toxicol Appl Pharmacol 161:82-99.
10. European Collaborative Study. 2005. Mother to child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40:458-465.
11. Giaretti W, Rapallo A, Geido E, Sciutto A, Merlo F, Risio M, Rossini FP. 1998. Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation. Am J Pathol 153:1201-1209.
12. Grollman AP, Moriya M. 1993. Mutagen by 8-oxoguanine: an enemy within. Trends Genet 9:246-249.
13. Hailer MK, Slade PG, Martin BD, Rosenquist TA, Sugden KD. 2005. Recognition of the oxidized lesions spiroiminodihydantoin and guanidinohydantoin in DNA by the mammalian base excision repair glycosylases NEIL1 and NEIL2. DNA Repair 4:41-50.
14. Henderson PT, Delaney JC, Muller JG, Neeley WL, Tannenbaum SR, Burrows CJ, Essigmann JM. 2003. The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo. Biochemistry 42:9257-9262.
15. Hong HL, Dunnick J, Herbert R, Devereux TR, Kim Y, Sills RC. 2007. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT. Environ Mol Mutagen 48:299-306.
16. International Agency for Research on Cancer. 2000. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents, Vol. 76. Lyon: IARC. pp 35-127.
17. Kino K, Sugiyama H. 2005. UVR-induced G-C to C-G transversions from oxidative DNA damage. Mutat Res 571:33-42.
18. Kornyushyna O, Berges AM, Muller JG, Burrows CJ. 2002. In vitro nucleotide misinsertion opposite the oxidized guanosine lesions spiroiminodihydantoin and guanidinohydantoin and DNA synthesis past the lesions using Escherichia coli DNA polymerase I (Klenow fragment). Biochemistry 41:15304-15314.
19. Meng Q, Walker DM, Olivero OA, Shi X, Antiochos BB, Poirier MC, Walker VE. 2000. Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc Natl Acad Sci USA 97:12667-12671.
20. Meng Q, Olivero OA, Fasco MJ, Bellisario R, Kaminsky LS, Pass KA, Abrams EJ, Wade NA, Poirier MC, Walker VE, Protocol team. 2007. Plasma and cellular markers of AZT metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs. Environ Mol Mutagen 48:307-321.
21. Moerkerk P, Arends JW, van Driel M, de Bruïne A, de Goeij A, ten Kate J. 1994. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 54:3376-3378.
22. Mofenson LM. 2004. Sucesses and challenges in the perinatal HIV-1 epidemic in the United States as illustrated by the HIV-1 serosurvey of child-bearing women. Arch Pediatr Adolesc Med 158:422-425.
23. Moriya M, Ou C, Bodepudi V, Johnson F, Takeshita M, Grollman AP. 1991. Site-specific mutagenesis using a gapped duplex vector: A study of translesion synthesis past 8-oxodeoxyguanosine in E. coli. Mutat Res 254:281-288.
24. National Toxicology Program. 2006. NTP Toxicology and Carcinogenesis Studies of Transplacental 30-Azido-30-Dioxythymidine (AZT) (CAS No. 30516-87-1) in Swiss (CD-1(R)) Mice (in utero Studies). Natl Toxicol Program Tech Rep Ser 522:1-184.
25. Niles JC, Wishnok JS, Tannenbaum SR. 2006. Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide 14:109-121.
26. Olivero OA, Beland FA, Fullerton NF, Poirier MC. 1994. Vaginal epithelial DNA damage and expression of preneoplastic markers in mice during chronic dosing with tumorigenic levels of 3′-azido-2′,3′- dideoxythymidine. Cancer Res 54:6235-6242.
27. Olivero OA, Anderson LM, Diwan BA, Haines DC, Harbaugh SW, Moskal TJ, Jones AB, Rice JM, Riggs CW, Logsdon D, Yuspa SH, Poirier MC. 1997. Transplacental effects of 30-azido-20,30-dideoxythymidine (AZT): Tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst 89:1602-1608.
28. Olivero OA, Shearer GM, Chougnet CA, Kovacs AAS, Landay AL, Baker R, Stek AM, Khoury MM, Proia LA, Kessler HA, others. 1999. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS 13:919-925.
29. Olivero OA, Fernandez JJ, Antiochos BB, Wagner JL, St Claire ME, Poirier MC. 2002. Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. J Acquir Immune Defic Syndr 29:323-329.
30. Phillips MD, Nascimbeni B, Tice RR, Shelby MD. 1991. Induction of micronuclei in mouse bone marrow cells: an evaluation of nucleoside analogues used in the treatment of AIDS. Environ Mol Mutagen 18:168-183.
31. Poirier MC, Olivero OA, Walker DM, Walker VE. 2004. Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol 199:151-161.
32. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
33. Shibutani S, Takeshita M, Grollman AP. 1991. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349:431-434.
34. Sills RC, Hong HL, Greenwell A, Herbert RA, Boorman GA, Devereux TR. 1995. Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. Carcinogenesis 16:1623-1628.
35. Slade PG, Hailer MK, Brook DM, Sugden KD. 2005. Guanine-specific oxidation of double-stranded DNA by Cr(VI) and ascorbic acid forms spiroiminodihydantoin and 8-oxo-2′-deoxyguanosine. Chem Res Toxicol 18:1140-1149.
36. Steinbrook R. 2004. The AIDS epidemic in 2004. N Engl J Med 351:115-117.
37. Sugden KD, Campo CK, Martin BD. 2001. Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: a possible mechanism for chromate genotoxicity. Chem Res Toxicol 14:1315-1322.
38. Suzuki T, Friesen MD, Ohshima H. 2003. Formation of a diimino-imidazole nucleoside from 2′-deoxyguanosine by singlet oxygen generated by methylene blue photooxidation. Bioorg Med Chem 11:2157-2162.
39. Ton TV, Hong HH, Anna CH, Dunnick JK, Devereux TR, Sills RC, Kim Y. 2004. Predominant K-ras codon 12 G -> A transition in chemically induced lung neoplasms in B6C3F1 mice. Toxicol Pathol 32:16-21.
40. Vivet-Boudou V, Didierjean J, Isel C, Marquet R. 2006. Nucleoside and nucleotide inhibitors of HIV-1 replication. Cell Mol Life Sci 63:163-186.
41. Von Tungelin LS, Williams LD, Doerge DR, Shaddock JG, Mc Garrity LJ, Morris SM, Mittelstaedt RA, Heflich RH, Beland FA. 2007. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine. Environ Mol Mutagen 48:258-269.
42. Wei S, Liang Z, Gao J, Wu S, Zhu H, Liu H, Liu T. 2005. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection PCR, direct sequencing. J Gastroenterol Hepatol 20:67-72.
43. Wessner LL, Fan M, Schaeffer DO, McEntee MF, Miller MS. 1996. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis 17:1519-1526.
44. Witt KL, Tice RR, Wolfe GW, Bishop JB. 2004. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3-azido-3-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment. Environ Mol Mutagen 44:321-328.
45. Witt KL, Cummingham CK, Patterson KB, Kissling GE, Dertinger SD, Livingston E, Bishop JB. 2007. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV. Environ Mol Mutagen 48:322-329.
46. ox) and spiroiminodihydantoin (Sp) are major products of iron- and copper-mediated 8-oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine oxidation. Mol Biosyst 1:373-381.
47. Wood ML, Esteve A, Morningstar ML, Kuziemko GM, Essigmann JM. 1992. Genetic effects of oxidative DNA damage: comparative mutagenesis of 7,8-dihydro-8-oxoguanine and 7,8-dihydro-8-oxoadenine in Escherichia coli. Nucleic Acids Res 20:6023-6032.
48. Zhang A, Diwan BA, Anderson LM, Logsdon D, Olivero OA, Haines DC, Rice JM, Yuspa SH, Poirier MC. 1998. Skin tumorigenesis and Ki-ras and H-ras mutations in tumors from adult mice exposed in utero to 30-azido-30-deoxythymidine. Mol Carcinog 23:45-51.